S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
agilon health, inc. stock logo
AGL
agilon health
$4.46
-9.9%
$5.88
$4.44
$28.99
$1.83B0.495.89 million shs5.91 million shs
DaVita Inc. stock logo
DVA
DaVita
$129.96
-0.4%
$129.34
$71.51
$141.54
$11.44B1.04504,346 shs449,306 shs
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$18.75
+2.0%
$19.56
$16.37
$27.72
$10.79B1286,387 shs516,069 shs
Progyny, Inc. stock logo
PGNY
Progyny
$33.81
-1.1%
$37.28
$29.44
$44.95
$3.30B1.48629,281 shs627,213 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
agilon health, inc. stock logo
AGL
agilon health
-9.90%-13.98%-16.17%-40.45%-84.33%
DaVita Inc. stock logo
DVA
DaVita
-0.35%-2.80%-4.90%+23.98%+54.79%
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
+1.93%-0.82%-1.55%-4.46%-19.41%
Progyny, Inc. stock logo
PGNY
Progyny
-1.14%-5.66%-3.87%-11.82%+4.38%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
agilon health, inc. stock logo
AGL
agilon health
1.2137 of 5 stars
4.11.00.00.01.10.00.6
DaVita Inc. stock logo
DVA
DaVita
3.3544 of 5 stars
1.22.00.04.52.02.52.5
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
4.7752 of 5 stars
3.15.02.50.03.50.05.0
Progyny, Inc. stock logo
PGNY
Progyny
4.3301 of 5 stars
4.51.00.00.02.93.33.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
agilon health, inc. stock logo
AGL
agilon health
2.19
Hold$9.73118.18% Upside
DaVita Inc. stock logo
DVA
DaVita
2.33
Hold$118.50-8.82% Downside
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
2.13
Hold$24.0028.03% Upside
Progyny, Inc. stock logo
PGNY
Progyny
3.00
Buy$48.3042.86% Upside

Current Analyst Ratings

Latest AGL, FMS, DVA, and PGNY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/6/2024
agilon health, inc. stock logo
AGL
agilon health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageUnderweight$5.00
3/6/2024
DaVita Inc. stock logo
DVA
DaVita
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$133.00
2/29/2024
agilon health, inc. stock logo
AGL
agilon health
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $9.00
2/29/2024
agilon health, inc. stock logo
AGL
agilon health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$10.00 ➝ $7.50
2/28/2024
agilon health, inc. stock logo
AGL
agilon health
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$7.00 ➝ $6.00
2/28/2024
agilon health, inc. stock logo
AGL
agilon health
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$11.00 ➝ $8.00
2/28/2024
Progyny, Inc. stock logo
PGNY
Progyny
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$48.00
2/28/2024
Progyny, Inc. stock logo
PGNY
Progyny
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$47.00 ➝ $46.00
2/28/2024
Progyny, Inc. stock logo
PGNY
Progyny
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$45.00 ➝ $43.00
2/26/2024
agilon health, inc. stock logo
AGL
agilon health
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$25.00 ➝ $6.50
2/26/2024
agilon health, inc. stock logo
AGL
agilon health
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform$12.00 ➝ $6.50
(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
agilon health, inc. stock logo
AGL
agilon health
$4.32B0.42N/AN/A$1.63 per share2.74
DaVita Inc. stock logo
DVA
DaVita
$12.14B0.94$16.75 per share7.76$13.63 per share9.53
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$21.05B0.52$4.71 per share3.98$27.34 per share0.69
Progyny, Inc. stock logo
PGNY
Progyny
$1.09B3.00$0.66 per share50.96$5.77 per share5.86

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
agilon health, inc. stock logo
AGL
agilon health
-$262.60M-$0.65N/AN/AN/A-5.76%-21.74%-8.89%5/14/2024 (Estimated)
DaVita Inc. stock logo
DVA
DaVita
$691.53M$7.4017.5612.981.165.70%64.42%4.63%5/13/2024 (Estimated)
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$540.07M$0.9220.389.610.892.56%4.99%2.15%5/14/2024 (Estimated)
Progyny, Inc. stock logo
PGNY
Progyny
$62.04M$0.6254.5334.861.415.70%12.64%8.82%5/13/2024 (Estimated)

Latest AGL, FMS, DVA, and PGNY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/27/2024Q4 2023
agilon health, inc. stock logo
AGL
agilon health
-$0.28-$0.41-$0.13-$0.25$1.02 billion$1.06 billion    
2/27/2024Q4 2023
Progyny, Inc. stock logo
PGNY
Progyny
$0.09$0.13+$0.04$0.13$274.08 million$269.94 million      
2/20/2024Q4 2023
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$0.36$0.47+$0.11$0.60$5.32 billion$5.37 billion
2/13/2024Q4 23
DaVita Inc. stock logo
DVA
DaVita
$1.53$1.87+$0.34$2.12$3.01 billion$3.15 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
agilon health, inc. stock logo
AGL
agilon health
N/AN/AN/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$0.422.24%-5.51%45.65%N/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
agilon health, inc. stock logo
AGL
agilon health
0.05
1.51
1.51
DaVita Inc. stock logo
DVA
DaVita
6.65
1.19
1.13
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
0.47
1.42
1.07
Progyny, Inc. stock logo
PGNY
Progyny
N/A
3.44
3.44

Ownership

Institutional Ownership

CompanyInstitutional Ownership
agilon health, inc. stock logo
AGL
agilon health
N/A
DaVita Inc. stock logo
DVA
DaVita
90.12%
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
8.25%
Progyny, Inc. stock logo
PGNY
Progyny
94.93%

Insider Ownership

CompanyInsider Ownership
agilon health, inc. stock logo
AGL
agilon health
3.30%
DaVita Inc. stock logo
DVA
DaVita
1.40%
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
N/A
Progyny, Inc. stock logo
PGNY
Progyny
14.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
agilon health, inc. stock logo
AGL
agilon health
1,117409.54 million396.03 millionNot Optionable
DaVita Inc. stock logo
DVA
DaVita
70,00087.70 million86.47 millionOptionable
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
1,358586.83 millionN/AOptionable
Progyny, Inc. stock logo
PGNY
Progyny
56396.50 million82.99 millionOptionable

AGL, FMS, DVA, and PGNY Headlines

SourceHeadline
Progyny, Inc. (NASDAQ:PGNY) Shares Bought by DekaBank Deutsche GirozentraleProgyny, Inc. (NASDAQ:PGNY) Shares Bought by DekaBank Deutsche Girozentrale
marketbeat.com - April 13 at 5:58 AM
Benjamin Graham Detailed Fundamental Analysis - PGNYBenjamin Graham Detailed Fundamental Analysis - PGNY
nasdaq.com - April 10 at 2:16 PM
Baillie Gifford & Co. Decreases Holdings in Progyny, Inc. (NASDAQ:PGNY)Baillie Gifford & Co. Decreases Holdings in Progyny, Inc. (NASDAQ:PGNY)
marketbeat.com - April 10 at 8:34 AM
International Assets Investment Management LLC Raises Stock Position in Progyny, Inc. (NASDAQ:PGNY)International Assets Investment Management LLC Raises Stock Position in Progyny, Inc. (NASDAQ:PGNY)
marketbeat.com - April 6 at 7:08 AM
Progyny CFO sells over $419k in company stockProgyny CFO sells over $419k in company stock
investing.com - April 5 at 4:04 AM
Progyny executive chairman sells $37,522 in stockProgyny executive chairman sells $37,522 in stock
investing.com - April 5 at 4:04 AM
Progyny, Inc. (NASDAQ:PGNY) Shares Sold by Riverbridge Partners LLCProgyny, Inc. (NASDAQ:PGNY) Shares Sold by Riverbridge Partners LLC
marketbeat.com - April 5 at 12:49 AM
Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to CoastProgyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast
globenewswire.com - April 4 at 8:59 AM
Progyny, Inc. (NASDAQ:PGNY) Chairman Sells $37,520.00 in StockProgyny, Inc. (NASDAQ:PGNY) Chairman Sells $37,520.00 in Stock
insidertrades.com - April 4 at 6:52 AM
Progyny, Inc. (NASDAQ:PGNY) Given Average Recommendation of "Buy" by AnalystsProgyny, Inc. (NASDAQ:PGNY) Given Average Recommendation of "Buy" by Analysts
marketbeat.com - April 4 at 2:15 AM
Insider Sell: President Michael Sturmer Sells Shares of Progyny Inc (PGNY)Insider Sell: President Michael Sturmer Sells Shares of Progyny Inc (PGNY)
finance.yahoo.com - April 3 at 9:07 PM
Progyny, Inc. (NASDAQ:PGNY) Chairman David J. Schlanger Sells 1,000 SharesProgyny, Inc. (NASDAQ:PGNY) Chairman David J. Schlanger Sells 1,000 Shares
marketbeat.com - April 3 at 6:58 PM
Executive Chairman David Schlanger Sells 71,272 Shares of Progyny Inc (PGNY)Executive Chairman David Schlanger Sells 71,272 Shares of Progyny Inc (PGNY)
finance.yahoo.com - March 30 at 8:04 AM
Progyny, Inc. (NASDAQ:PGNY) Chairman David J. Schlanger Sells 71,272 SharesProgyny, Inc. (NASDAQ:PGNY) Chairman David J. Schlanger Sells 71,272 Shares
insidertrades.com - March 30 at 7:15 AM
Insider Selling: Progyny, Inc. (NASDAQ:PGNY) Chairman Sells 71,272 Shares of StockInsider Selling: Progyny, Inc. (NASDAQ:PGNY) Chairman Sells 71,272 Shares of Stock
marketbeat.com - March 29 at 9:16 PM
Vanguard Group Inc. Has $277.52 Million Stake in Progyny, Inc. (NASDAQ:PGNY)Vanguard Group Inc. Has $277.52 Million Stake in Progyny, Inc. (NASDAQ:PGNY)
marketbeat.com - March 29 at 4:18 AM
Progyny, Inc. (NASDAQ:PGNY) Chairman Sells $97,777.05 in StockProgyny, Inc. (NASDAQ:PGNY) Chairman Sells $97,777.05 in Stock
insidertrades.com - March 28 at 8:45 AM
Executive Chairman David Schlanger Sells Shares of Progyny Inc (PGNY)Executive Chairman David Schlanger Sells Shares of Progyny Inc (PGNY)
finance.yahoo.com - March 28 at 3:15 AM
Fort Washington Investment Advisors Inc. OH Raises Stock Position in Progyny, Inc. (NASDAQ:PGNY)Fort Washington Investment Advisors Inc. OH Raises Stock Position in Progyny, Inc. (NASDAQ:PGNY)
marketbeat.com - March 26 at 11:08 AM
David J. Schlanger Sells 5,826 Shares of Progyny, Inc. (NASDAQ:PGNY) StockDavid J. Schlanger Sells 5,826 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock
insidertrades.com - March 26 at 4:30 AM
Citigroup Inc. Cuts Stock Position in Progyny, Inc. (NASDAQ:PGNY)Citigroup Inc. Cuts Stock Position in Progyny, Inc. (NASDAQ:PGNY)
marketbeat.com - March 21 at 4:38 AM
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor ForumProgyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
globenewswire.com - March 18 at 12:00 PM
American Century Companies Inc. Has $41.59 Million Stake in Progyny, Inc. (NASDAQ:PGNY)American Century Companies Inc. Has $41.59 Million Stake in Progyny, Inc. (NASDAQ:PGNY)
marketbeat.com - March 18 at 4:46 AM
PGNY Apr 2024 20.000 callPGNY Apr 2024 20.000 call
finance.yahoo.com - March 16 at 10:56 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

agilon health logo

agilon health

NYSE:AGL
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
DaVita logo

DaVita

NYSE:DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Fresenius Medical Care logo

Fresenius Medical Care

NYSE:FMS
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Progyny logo

Progyny

NASDAQ:PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.